Method development and validation for multi-component analysis of lamivudine & tenofovir disoproxil fumarate in bulk drug by UV-visible spectrophotometer & RP-HPLC

A novel, simple, precise and accurate method developed for the estimation of Lamivudine and tenofovir disoproxil fumarate (TDF) in bulk drug form has been established. Lamivudine and tenofovir are well known drugs and used in treatment of HIV- Ⅰ. The method was performed by using   C18 column, ODS H...

Full description

Bibliographic Details
Main Authors: Shweta Sharma, Amar Deep Ankalgi, Pooja Kaushal, M. S. Ashawat
Format: Article
Language:English
Published: Creative Pharma Assent 2020-11-01
Series:Journal of Applied Pharmaceutical Research
Subjects:
Online Access:https://japtronline.com/index.php/joapr/article/view/172
_version_ 1819140010408935424
author Shweta Sharma
Amar Deep Ankalgi
Pooja Kaushal
M. S. Ashawat
author_facet Shweta Sharma
Amar Deep Ankalgi
Pooja Kaushal
M. S. Ashawat
author_sort Shweta Sharma
collection DOAJ
description A novel, simple, precise and accurate method developed for the estimation of Lamivudine and tenofovir disoproxil fumarate (TDF) in bulk drug form has been established. Lamivudine and tenofovir are well known drugs and used in treatment of HIV- Ⅰ. The method was performed by using   C18 column, ODS Hypersil column with UV detection at 262nm by using Acetonitrile and water in ratio 55:45. The retention time was found to be 2.8 and 6.8 min for Lamivudine and tenofovir disoproxil fumarate (TDF). The linearity was found in range of 6- 14µg/ml for Lamivudine and 10- 50µg/ml for Tenofovir disoproxil fumarate with flow rate 1ml/min. the method was validated for linearity, accuracy, precision and robustness as per ICH guidelines. This method is suitable for simultaneous analysis for both the nucleoside analog reverse- transcriptase inhibitors
first_indexed 2024-12-22T11:31:45Z
format Article
id doaj.art-c405453d912c4868b042aff5d4f4e4df
institution Directory Open Access Journal
issn 2348-0335
language English
last_indexed 2024-12-22T11:31:45Z
publishDate 2020-11-01
publisher Creative Pharma Assent
record_format Article
series Journal of Applied Pharmaceutical Research
spelling doaj.art-c405453d912c4868b042aff5d4f4e4df2022-12-21T18:27:36ZengCreative Pharma AssentJournal of Applied Pharmaceutical Research2348-03352020-11-0184707610.18231/j.joapr.2020.v.8.i.4.70.76172Method development and validation for multi-component analysis of lamivudine & tenofovir disoproxil fumarate in bulk drug by UV-visible spectrophotometer & RP-HPLCShweta Sharma0Amar Deep Ankalgi1https://orcid.org/0000-0002-0775-9998Pooja Kaushal2https://orcid.org/0000-0003-4159-6990M. S. Ashawat3Department of Pharmaceutical Analysis and Quality Assurance, Laureate Institute of Pharmacy, Kathog, Jawalamukhi, Himachal Pradesh-176031Department of Pharmaceutical Analysis and Quality Assurance, Laureate Institute of Pharmacy, Kathog, Jawalamukhi, Himachal Pradesh-176031Department of Pharmaceutical Analysis and Quality Assurance, Laureate Institute of Pharmacy, Kathog, Jawalamukhi, Himachal Pradesh-176031Department of Pharmaceutical Analysis and Quality Assurance, Laureate Institute of Pharmacy, Kathog, Jawalamukhi, Himachal Pradesh-176031A novel, simple, precise and accurate method developed for the estimation of Lamivudine and tenofovir disoproxil fumarate (TDF) in bulk drug form has been established. Lamivudine and tenofovir are well known drugs and used in treatment of HIV- Ⅰ. The method was performed by using   C18 column, ODS Hypersil column with UV detection at 262nm by using Acetonitrile and water in ratio 55:45. The retention time was found to be 2.8 and 6.8 min for Lamivudine and tenofovir disoproxil fumarate (TDF). The linearity was found in range of 6- 14µg/ml for Lamivudine and 10- 50µg/ml for Tenofovir disoproxil fumarate with flow rate 1ml/min. the method was validated for linearity, accuracy, precision and robustness as per ICH guidelines. This method is suitable for simultaneous analysis for both the nucleoside analog reverse- transcriptase inhibitorshttps://japtronline.com/index.php/joapr/article/view/172lamivudinetenofovir disoproxil fumarateanti-hivrp-hplc
spellingShingle Shweta Sharma
Amar Deep Ankalgi
Pooja Kaushal
M. S. Ashawat
Method development and validation for multi-component analysis of lamivudine & tenofovir disoproxil fumarate in bulk drug by UV-visible spectrophotometer & RP-HPLC
Journal of Applied Pharmaceutical Research
lamivudine
tenofovir disoproxil fumarate
anti-hiv
rp-hplc
title Method development and validation for multi-component analysis of lamivudine & tenofovir disoproxil fumarate in bulk drug by UV-visible spectrophotometer & RP-HPLC
title_full Method development and validation for multi-component analysis of lamivudine & tenofovir disoproxil fumarate in bulk drug by UV-visible spectrophotometer & RP-HPLC
title_fullStr Method development and validation for multi-component analysis of lamivudine & tenofovir disoproxil fumarate in bulk drug by UV-visible spectrophotometer & RP-HPLC
title_full_unstemmed Method development and validation for multi-component analysis of lamivudine & tenofovir disoproxil fumarate in bulk drug by UV-visible spectrophotometer & RP-HPLC
title_short Method development and validation for multi-component analysis of lamivudine & tenofovir disoproxil fumarate in bulk drug by UV-visible spectrophotometer & RP-HPLC
title_sort method development and validation for multi component analysis of lamivudine tenofovir disoproxil fumarate in bulk drug by uv visible spectrophotometer rp hplc
topic lamivudine
tenofovir disoproxil fumarate
anti-hiv
rp-hplc
url https://japtronline.com/index.php/joapr/article/view/172
work_keys_str_mv AT shwetasharma methoddevelopmentandvalidationformulticomponentanalysisoflamivudinetenofovirdisoproxilfumarateinbulkdrugbyuvvisiblespectrophotometerrphplc
AT amardeepankalgi methoddevelopmentandvalidationformulticomponentanalysisoflamivudinetenofovirdisoproxilfumarateinbulkdrugbyuvvisiblespectrophotometerrphplc
AT poojakaushal methoddevelopmentandvalidationformulticomponentanalysisoflamivudinetenofovirdisoproxilfumarateinbulkdrugbyuvvisiblespectrophotometerrphplc
AT msashawat methoddevelopmentandvalidationformulticomponentanalysisoflamivudinetenofovirdisoproxilfumarateinbulkdrugbyuvvisiblespectrophotometerrphplc